Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results

Summary

  • Bausch Health Companies stock experienced a significant drop after posting its first-quarter results, missing expectations by 13 cents.
  • The company's debt maturity profile raises concerns for investors, with a large amount of debt maturing in 2025 and even more in 2027-2028.
  • Despite the challenges, Bausch Health sees opportunities for growth, particularly in its Xifaxan product and Solta Medical unit, and has issued a full-year revenue target of $4.70 billion to $4.85 billion.
  • BHC stock's grades discussed.
  • Looking for a portfolio of ideas like this one? Members of DIY Value Investing get exclusive access to our subscriber-only portfolios. Learn More »

Bausch Health US headquarters in Bridgewater, NJ, USA.

JHVEPhoto

Ahead of posting its first-quarter results, Bausch Health Companies Inc. (NYSE:BHC) reached a 52-week high in the last month. Bargain hunters who bought the stock since last Nov. 2023 did not expect the stock to lose 15.3% in

Please [+]Follow me for coverage on deeply-discounted stocks. Click on the "follow" button beside my name. Get do-it-yourself tips and tricks for free here:

  • Subscribe->[Y] Free
  • Subscribe->[ ] Basic (69% off Full Service)
  • Subscribe->[ ] Full Service

This article was written by

34.83K Followers

Chris Lau is an individual investor and economist with 30 years of experience covering life science, technology, and dividend-growth income stocks. He has degrees in Microbiology and Economics.

Chris runs the investing group DIY Value Investing where he shares his top stock picks of undervalued stocks with catalysts for upside, dividend-income recommendations with quant and payment calendar tracking, high upside plays, and research requests to help you become a better do-it-yourself investor. Learn more.

The returns from the public articles are: 2023 Average Return: 8.4% 2022 Average Return: 6.9% 2021 Average Return 29.9% 2020.

Flagship Products:

1. Top DIY Picks: Undervalued stocks have upcoming catalysts that markets do not expect.

2. Dividend-income Champs that have a long history of dividend growth. Includes printable calendar and quantitative scores.

3. DIY Risky Picks for a speculative allocation positive momentum for up to a moonshot, triple return.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About BHC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on BHC

Related Stocks

SymbolLast Price% Chg
BHC
--
BHC:CA
--